<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04884100</url>
  </required_header>
  <id_info>
    <org_study_id>2021-00586</org_study_id>
    <nct_id>NCT04884100</nct_id>
  </id_info>
  <brief_title>enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening</brief_title>
  <acronym>enHEART</acronym>
  <official_title>enHEART - Exploring Full Content of Optical Signals to Enhance Cardiac Arrhythmia Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research will investigate the PPG signal morphology related to physiological and non-&#xD;
      physiological changes in arrhythmia-related heart rate as well as the performance of the&#xD;
      PPG-based features previously developed within the framework of the Mini-Holter study to&#xD;
      discriminate between several cardiac arrhythmias. To this end, clinical data will be recorded&#xD;
      on patients by using a wrist-based PPG monitor simultaneously with 12-lead ECG and&#xD;
      intracardiac electrogram (EGM) signals at the university hospital in Lausanne. Importantly,&#xD;
      this study will remain purely observational as it will not change the diagnostic and&#xD;
      therapeutic management of the included patients, nor will it interfere with the time course&#xD;
      of the procedures. The aim of enHEART study is to validate on a larger database the ability&#xD;
      of several previously developed PPG-based features to detect a variety of cardiac&#xD;
      arrhythmias.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria :&#xD;
&#xD;
        1. Age &gt;=18 year old&#xD;
&#xD;
        2. Able to speak/read/understand French&#xD;
&#xD;
        3. Informed consentsigned, and&#xD;
&#xD;
        4. at least one of the following cardiac arrhythmias :&#xD;
&#xD;
             -  sustained or non-sustained ventricular tachycardia,&#xD;
&#xD;
             -  sustained or non-sustained atrial tachycardia,&#xD;
&#xD;
             -  atrial flutter,&#xD;
&#xD;
             -  frequent atrial and/or ventricular ectopic beats,,&#xD;
&#xD;
             -  ventricular and/or atrial bigeminy,&#xD;
&#xD;
             -  left bundle branch block,&#xD;
&#xD;
             -  second or third degree atrioventricular block,&#xD;
&#xD;
             -  atrioventricular reentrant tachycardia or atrioventricular node reentrant&#xD;
                tachycardia,&#xD;
&#xD;
             -  AF&#xD;
&#xD;
      Exclusion criteria :&#xD;
&#xD;
        1. Patient is pregnant or breastfeeding,&#xD;
&#xD;
        2. Refusal of participation by the patient,&#xD;
&#xD;
        3. Patient is less than 18 years old,&#xD;
&#xD;
        4. Patient incapable of judgement or under tutelage, or&#xD;
&#xD;
        5. Patient is already included in another human research projetc(ClinO/HRO) that may affect&#xD;
           the objectives of this study.&#xD;
&#xD;
      For women of childbearing age, a pregnancy test will be systematically performed before any&#xD;
      procedure.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2021</start_date>
  <completion_date type="Anticipated">June 15, 2025</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PPG-based arrhythmia detection</measure>
    <time_frame>2 years</time_frame>
    <description>The primary endpoint is to validate preliminary data of previously developed PPG-based arrhythmia classification algorithms compared to HRV-based algorithm (using 12-lead ECG and intracardiac EGM signals as gold-standard references).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">99</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Photoplethysmography (PPG)</condition>
  <arm_group>
    <arm_group_label>PPG recording</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>arrhythmia recording using PPG monitor</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Validating and improving PPG-based algorithms</intervention_name>
    <description>Our project aims at validating and improving PPG-based algorithms that were previously developed during the time course of a preceding study mini-Holter, accepted by the CER-VD in 2015. The developed features might help improve our understanding of the physio-pathological expression of cardiac arrhythmias. Indeed, current evidence demonstrates that PPG signals contain rich information on diverse cardiovascular mechanisms and properties</description>
    <arm_group_label>PPG recording</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥ 18-year-old,&#xD;
&#xD;
          2. Able to speak/read/understand French,&#xD;
&#xD;
          3. Informed consent signed, and&#xD;
&#xD;
          4. at least one of the following cardiac arrhythmias:&#xD;
&#xD;
               -  sustained or non-sustained ventricular tachycardia,&#xD;
&#xD;
               -  sustained or non-sustained atrial tachycardia&#xD;
&#xD;
               -  atrial flutter,&#xD;
&#xD;
               -  frequent atrial and/or ventricular ectopic beats,&#xD;
&#xD;
               -  ventricular and/or atrial bigeminy,&#xD;
&#xD;
               -  left bundle branch block,&#xD;
&#xD;
               -  second- or third-degree atrioventricular block,&#xD;
&#xD;
               -  atrioventricular reentrant tachycardia or atrioventricular node reentrant&#xD;
                  tachycardia,&#xD;
&#xD;
               -  AF&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient is pregnant or breastfeeding,&#xD;
&#xD;
          2. Refusal of participation by the patient&#xD;
&#xD;
          3. Patient is less than 18 years old,&#xD;
&#xD;
          4. Patient incapable of judgement or under tutelage, or&#xD;
&#xD;
          5. Patient is already included in another human research project (ClinO/HRO) that may&#xD;
             affect the objectives of this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 7, 2021</study_first_submitted>
  <study_first_submitted_qc>May 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2021</study_first_posted>
  <last_update_submitted>May 11, 2021</last_update_submitted>
  <last_update_submitted_qc>May 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Prof. Etienne Pruvot</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

